Physician profile
Charles A Smith
NPI 1518962984
$29,469.51
in general payments reported to CMS, 2019-2025
36 companies · $673 in 2025
The $673 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,807 · 2020: $959 · 2021: $714 · 2022: $4,987 · 2023: $14K · 2024: $5,162 · 2025: $673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $2,954 · Travel and Lodging: $926 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,101.50 |
| Food and Beverage | $2,954.08 |
| Travel and Lodging | $926.25 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $22,342.13 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $2,363.34 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $723.27 | 2019-2025 | |
| Medtronic, INC. | $632.20 | 2021-2025 | Corevalve Evolut R, Azure Xt Dr Mri Surescan, Linq II |
| Janssen Pharmaceuticals, INC | $475.35 | 2019-2024 | Xarelto |
| Pfizer INC. | $407.76 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $395.91 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $272.88 | 2021-2025 | Farxiga, Wainua |
| Cleerly, INC. | $210.57 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $204.97 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $172.57 | 2023-2024 | Watchman Flx, Watchman |
| Abbott Laboratories | $154.65 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $153.88 | 2019-2025 | Camzyos |
| Irhythm Technologies, INC. | $97.96 | 2023 | Zio Xt Patch |
| Inspire Medical Systems, INC. | $85.44 | 2024 | Inspire |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $76.17 | 2024 | Xarelto |
| Merck Sharp & Dohme LLC | $66.90 | 2023-2024 | Verquvo |
| Sanofi-Aventis U.S. LLC | $59.89 | 2019 | |
| Arbor Pharmaceuticals, INC. | $52.77 | 2019 | |
| Abiomed | $50.66 | 2025 | |
| Novo Nordisk INC | $50.14 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Amarin Pharma, INC. | $50.06 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $49.93 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $44.39 | 2019 | |
| Glaxosmithkline, LLC. | $42.81 | 2022-2024 | Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $36.70 | 2022-2024 | |
| Gilead Sciences, INC. | $36.38 | 2019 | |
| Alnylam Pharmaceuticals INC. | $24.36 | 2024 | Onpattro |
| Kiniksa Pharmaceuticals, LTD. | $20.31 | 2023 | Arcalyst |
| Convatec INC. | $20.05 | 2022 | |
| Esperion Therapeutics, INC. | $19.52 | 2023 | Nexletol |
| Baxter Healthcare | $16.95 | 2022 | |
| Lundbeck LLC | $16.13 | 2019 | |
| Mindray Ds USA, INC. | $15.00 | 2024 | Na Electrode,Indirect,International, Patient Monitor |
| Ethicon US, LLC | $14.50 | 2019 | |
| Biosense Webster, INC. | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.